Virtus ETF Advisers’s Dynavax Technologies DVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-26,917
| Closed | -$344K | – | 531 |
|
|
2024
Q4 | $344K | Sell |
26,917
-506
| -2% | -$6.12K | 0.14% | 207 |
|
|
2024
Q3 | $305K | Hold |
27,423
| – | – | 0.14% | 230 |
|
|
2024
Q2 | $308K | Buy |
27,423
+21,041
| +330% | +$245K | 0.15% | 225 |
|
|
2024
Q1 | $79.2K | Sell |
6,382
-441
| -6% | -$5.75K | 0.04% | 395 |
|
|
2023
Q4 | $95.4K | Sell |
6,823
-1,008
| -13% | -$14K | 0.06% | 382 |
|
|
2023
Q3 | $116K | Sell |
7,831
-785
| -9% | -$11K | 0.07% | 323 |
|
|
2023
Q2 | $111K | Sell |
8,616
-140
| -2% | -$1.59K | 0.07% | 343 |
|
|
2023
Q1 | $85.9K | Sell |
8,756
-3,371
| -28% | -$36K | 0.05% | 376 |
|
|
2022
Q4 | $129K | Buy |
12,127
+2,157
| +22% | +$25.1K | 0.07% | 391 |
|
|
2022
Q3 | $104K | Buy |
9,970
+66
| +0.7% | +$860 | 0.04% | 416 |
|
|
2022
Q2 | $125K | Sell |
9,904
-1,688
| -15% | -$17.9K | 0.05% | 370 |
|
|
2022
Q1 | $126K | Sell |
11,592
-685
| -6% | -$8.32K | 0.06% | 254 |
|
|
2021
Q4 | $173K | Sell |
12,277
-11,295
| -48% | -$186K | 0.07% | 269 |
|
|
2021
Q3 | $453K | Sell |
23,572
-1,227
| -5% | -$16.3K | 0.2% | 155 |
|
|
2021
Q2 | $244K | Sell |
24,799
-33,291
| -57% | -$303K | 0.1% | 216 |
|
|
2021
Q1 | $571K | Buy |
58,090
+1,028
| +2% | +$8.47K | 0.24% | 134 |
|
|
2020
Q4 | $254K | Buy |
57,062
+3,078
| +6% | +$13.9K | 0.11% | 306 |
|
|
2020
Q3 | $233K | Sell |
53,984
-7,347
| -12% | -$52.4K | 0.12% | 278 |
|
|
2020
Q2 | $544K | Buy |
+61,331
| New | +$310K | 0.26% | 138 |
|
|
2019
Q1 | – | Sell |
-57,838
| Closed | -$529K | – | 173 |
|
|
2018
Q4 | $529K | Buy |
57,838
+8,607
| +17% | +$95.3K | 0.09% | 76 |
|
|
2018
Q3 | $610K | Buy |
49,231
+3,317
| +7% | +$44.9K | 0.06% | 99 |
|
|
2018
Q2 | $700K | Sell |
45,914
-1,984
| -4% | -$34.3K | 0.62% | 100 |
|
|
2018
Q1 | $951K | Sell |
47,898
-2,828
| -6% | -$48.8K | 0.83% | 48 |
|
|
2017
Q4 | $949K | Buy |
50,726
+19,405
| +62% | +$390K | 1.19% | 35 |
|
|
2017
Q3 | $673K | Sell |
31,321
-6,856
| -18% | -$108K | 0.09% | 72 |
|
|
2017
Q2 | $368K | Buy |
+38,177
| New | +$248K | 0.05% | 81 |
|
|
2016
Q4 | – | Sell |
-17,302
| Closed | -$181K | – | 182 |
|
|
2016
Q3 | $181K | Hold |
17,302
| – | – | 0.09% | 145 |
|
|
2016
Q2 | $252K | Buy |
17,302
+7,534
| +77% | +$129K | 0.19% | 86 |
|
|
2016
Q1 | $188K | Sell |
9,768
-612
| -6% | -$12.4K | 0.26% | 93 |
|
|
2015
Q4 | $251K | Buy |
+10,380
| New | +$260K | 0.69% | 64 |
|
Other funds holding DVAX
DTC
TCM
CC
DM
Virtus ETF Advisers's DVAX Position: Q1 2025 in Review
Virtus ETF Advisers sold out of Dynavax Technologies (DVAX) in Q1 2025, closing a stake of 26,917 shares — an estimated $344K sold.
Virtus ETF Advisers first reported a position in DVAX in Q4 2015 and held it in 30 quarters. The position peaked at $951K in Q1 2018. 284 funds tracked by Wall St. Rank hold DVAX as of Q1 2025.
- Virtus ETF Advisers reported no remaining Dynavax Technologies position as of Q1 2025 after selling out during the quarter.
- Virtus ETF Advisers sold 26,917 Dynavax Technologies shares in Q1 2025, an estimated $344K.
- Virtus ETF Advisers first reported a position in Dynavax Technologies in Q4 2015 and held it in 30 quarters.
- Virtus ETF Advisers's Dynavax Technologies position peaked at $951K in Q1 2018.
- 284 funds tracked by Wall St. Rank held Dynavax Technologies as of Q1 2025.
Based on Virtus ETF Advisers's 13F filing for Q1 2025, filed 14 May 2025.